Ambu A/S
CSE:AMBU B
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
88.88
153.05
|
Price Target |
|
We'll email you a reminder when the closing price reaches DKK.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one AMBU B stock under the Base Case scenario is 103.98 DKK. Compared to the current market price of 113.95 DKK, Ambu A/S is Overvalued by 9%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Ambu A/S
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for AMBU B cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Economic Moat
Ambu A/S
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Ambu A/S
Balance Sheet Decomposition
Ambu A/S
Current Assets | 2.6B |
Cash & Short-Term Investments | 615m |
Receivables | 829m |
Other Current Assets | 1.2B |
Non-Current Assets | 4.5B |
PP&E | 1.1B |
Intangibles | 3.2B |
Other Non-Current Assets | 160m |
Current Liabilities | 1.1B |
Accounts Payable | 490m |
Other Current Liabilities | 569m |
Non-Current Liabilities | 501m |
Long-Term Debt | 483m |
Other Non-Current Liabilities | 18m |
Earnings Waterfall
Ambu A/S
Revenue
|
5.4B
DKK
|
Cost of Revenue
|
-2.2B
DKK
|
Gross Profit
|
3.2B
DKK
|
Operating Expenses
|
-2.6B
DKK
|
Operating Income
|
645m
DKK
|
Other Expenses
|
-410m
DKK
|
Net Income
|
235m
DKK
|
Free Cash Flow Analysis
Ambu A/S
DKK | |
Free Cash Flow | DKK |
Ambu showcased impressive fourth-quarter results with 10.6% revenue growth, driving a full-year organic growth of 13.8%, primarily from Endoscopy, which grew 19.7%. The EBIT margin stood at 10.6%, reflecting a solid performance despite increased operational expenses. For FY '24/'25, the company anticipates organic revenue growth of 10-13%, with Endoscopy projected at over 15%. Free cash flow is expected to exceed DKK 500 million. Ambu's strategic focus on new product launches, including a ureteroscope and videolaryngoscope, is expected to positively influence growth. The long-term EBIT margin target remains at 20%【4:3†source】【4:4†source】【4:2†source】.
What is Earnings Call?
AMBU B Profitability Score
Profitability Due Diligence
Ambu A/S's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Ambu A/S's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
AMBU B Solvency Score
Solvency Due Diligence
Ambu A/S's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Score
Ambu A/S's solvency score is 90/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AMBU B Price Targets Summary
Ambu A/S
Dividends
Current shareholder yield for AMBU B is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area offers a range of products such as resuscitators, face masks and laryngeal masks. The Patient Monitoring & Diagnostics business area comprises single use electrodes for cardiological and neurological examinations. The target groups for these products are hospitals, clinics, ambulance services and sleep labs. The Emergency Care business area offers ventilation bags, neck collars and manikins for first-aid training. The firm markets its products worldwide. The firm operates King Systems Inc, First Water Heathcote Ltd and Invendo Medical GmbH as subsidiaries.
Officers
The intrinsic value of one AMBU B stock under the Base Case scenario is 103.98 DKK.
Compared to the current market price of 113.95 DKK, Ambu A/S is Overvalued by 9%.